Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yana Sui"'
Publikováno v:
Experimental & Therapeutic Medicine; Aug2023, Vol. 26 Issue 2, p1-5, 5p
Publikováno v:
Molecular Medicine Reports
Paclitaxel is the most frequently used therapy regimen for triple‑negative breast cancer (TNBC). However, chemoresistance frequently occurs, leading to enhanced failure rates of chemotherapy in TNBC; therefore, novel biological therapies are urgent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f4baf447606efe821de4ae1649184f
http://europepmc.org/articles/PMC6797991
http://europepmc.org/articles/PMC6797991
Publikováno v:
Oncology Letters
Gastric cancer (GC), the second most common malignant cancer worldwide, gives rise to a number of cancer-associated fatalities annually. Accumulating evidence has shown that microRNAs (miRs) may serve as oncogenes or tumor suppressors in GC developme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a8259d1f07a0db7e774f2e64dad3a0
http://europepmc.org/articles/PMC6704297
http://europepmc.org/articles/PMC6704297
Publikováno v:
Experimental and Therapeutic Medicine
Long non-coding RNAs (lncRNAs) and microRNAs (miRs) have critical roles in the progression of various diseases. The present study aimed to investigate the levels and clinical significance of lncRNA taurine upregulated gene 1 (TUG1) and miR-145-5p in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede04c217312d6a37943c223f94faa5c
https://pubmed.ncbi.nlm.nih.gov/34659508
https://pubmed.ncbi.nlm.nih.gov/34659508
Publikováno v:
Molecular Medicine Reports
The incidence of thyroid cancer has increased the past few decades, the most frequent type has been identified to be the papillary thyroid carcinoma (PTC). Following thyroidectomy, radioiodine ablation treatment on PTC is routinely performed. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338af16e8eebad05c1a373bbb9c1419b
http://europepmc.org/articles/PMC5983951
http://europepmc.org/articles/PMC5983951
Publikováno v:
Oncology Letters. Sep2017, Vol. 14 Issue 3, p3455-3462. 8p.
Publikováno v:
Oncology Letters
Breast cancer is the second leading cause of cancer-associated mortality in females in the USA. Hsa-miR-599 was demonstrated to function as a tumour suppressor during cancer progression. However, the function and mechanism of the hsa-miR-599 in human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72bc2cbc5164a089abd18879b1691544
https://pubmed.ncbi.nlm.nih.gov/28927100
https://pubmed.ncbi.nlm.nih.gov/28927100